La Jolla Pharmaceutical Company
Biotechnology Research
Waltham, MA 25,891 followers
People | Passion | Planning | Performance
About us
La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
- Website
-
https://www.lajollapharmaceutical.com/
External link for La Jolla Pharmaceutical Company
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, MA
- Type
- Privately Held
- Founded
- 1989
Locations
-
Primary
Get directions
201 Jones Rd, Suite 400
Waltham, MA 02451, US